Shareholder alert: class action lawsuit filed on behalf of lifecore biomedical, inc. (lfcr) investors – holzer & holzer, llc encourages investors with significant losses to contact the firm

Atlanta, july 30, 2024 (globe newswire) -- a shareholder class action lawsuit has been filed against lifecore biomedical, inc. (“lifecore” or the “company”) (nasdaq: lfcr). the lawsuit alleges that defendants made materially false and misleading statements and/or failed to disclose adverse information regarding the company's business, operations, and prospects, including allegations that: (i) lifecore maintained deficient internal controls over financial reporting; (ii) as a result, the company issued several financial statements that were inaccurate and would need to be restated; (iii) lifecore's purported remediation efforts with respect to the foregoing deficiencies were ineffective; (iv) all of the foregoing impaired lifecore's ability to timely file periodic reports with the sec in compliance with nasdaq listing requirements; and (v) accordingly, the company's financial position and/or prospects were materially overstated.
LFCR Ratings Summary
LFCR Quant Ranking